The Reynold Lemkins Group (Asia) Limited increased their stake in ITC PROPERTIES (00199) by 100.8 million shares, at a price of 0.7 Hong Kong dollars per share.
On November 24th, The Reynold Lemkins Group (Asia) Limited increased its stake in Deson Development International Holdings Limited (00199) by 100.8 million shares, with a price of HK$0.70 per share, for a total amount of approximately HK$70.56 million.
The latest data from the Hong Kong Stock Exchange shows that on November 24, The Reynold Lemkins Group (Asia) Limited increased its holdings of ITC PROPERTIES (00199) by 100.8 million shares, with a price of HK$0.70 per share, for a total amount of approximately HK$70.56 million. After the increase, the latest number of shares held is approximately 100.8 million shares, with a latest holding ratio of 11.11%.
This transaction involves related parties: Reynold Lemkins Holding CO., LTD, The Reynold Lemkins Group, and Liu Haoran.
Related Articles
HK Stock Market Move | Metallurgical Corporation of China (01618) opens down nearly 6%, planning to sell its assets including China Metallurgical Group and China Metallurgical Copper-Zinc for 60.7 billion yuan.
HK Stock Market Move | CONCORD HC GP(02453) opened more than 6%, its subsidiary Guangzhou Taihe Cancer Hospital has been approved to enter the list of designated medical institutions of "Hong Kong and Macao Medical Devices Pass"
HK Stock Market Move | ASCLETIS-B (01672) opened nearly 15% higher. Positive topline results were obtained from the 13-week Phase II study of ASC30 for the treatment of obesity.
HK Stock Market Move | Metallurgical Corporation of China (01618) opens down nearly 6%, planning to sell its assets including China Metallurgical Group and China Metallurgical Copper-Zinc for 60.7 billion yuan.
HK Stock Market Move | CONCORD HC GP(02453) opened more than 6%, its subsidiary Guangzhou Taihe Cancer Hospital has been approved to enter the list of designated medical institutions of "Hong Kong and Macao Medical Devices Pass"
HK Stock Market Move | ASCLETIS-B (01672) opened nearly 15% higher. Positive topline results were obtained from the 13-week Phase II study of ASC30 for the treatment of obesity.
RECOMMEND
Baidu’s AI Ace Kunlunxin Prepares For Hong Kong IPO, Domestic Computing Power Faces Crucial Test
08/12/2025
Institutions Say Short-Term Volatility Does Not Alter Upward Trend Of Hong Kong Stocks, Hang Seng Index Still Expected To Challenge 30,000 Points Next Year
08/12/2025
As The 2025 Central Economic Work Conference Approaches, What New Expectations Lie Ahead For Next Year’s Economic Agenda? Institutions Forecast Five Key Highlights
08/12/2025
